These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 28978805)

  • 1. Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma.
    Lo A; Li CP; Buza EL; Blomberg R; Govindaraju P; Avery D; Monslow J; Hsiao M; Puré E
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
    Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
    BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance.
    Fearon DT
    Cancer Immunol Res; 2014 Mar; 2(3):187-93. PubMed ID: 24778314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma.
    Patsouras D; Papaxoinis K; Kostakis A; Safioleas MC; Lazaris AC; Nicolopoulou-Stamati P
    Mol Med Rep; 2015 Jun; 11(6):4585-90. PubMed ID: 25625587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.
    Feig C; Jones JO; Kraman M; Wells RJ; Deonarine A; Chan DS; Connell CM; Roberts EW; Zhao Q; Caballero OL; Teichmann SA; Janowitz T; Jodrell DI; Tuveson DA; Fearon DT
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20212-7. PubMed ID: 24277834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
    Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD
    BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha.
    Kraman M; Bambrough PJ; Arnold JN; Roberts EW; Magiera L; Jones JO; Gopinathan A; Tuveson DA; Fearon DT
    Science; 2010 Nov; 330(6005):827-30. PubMed ID: 21051638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
    Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
    Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.
    Liu J; Huang C; Peng C; Xu F; Li Y; Yutaka Y; Xiong B; Yang X
    BMC Cancer; 2018 Nov; 18(1):1099. PubMed ID: 30419872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.
    Shi M; Yu DH; Chen Y; Zhao CY; Zhang J; Liu QH; Ni CR; Zhu MH
    World J Gastroenterol; 2012 Feb; 18(8):840-6. PubMed ID: 22371645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.
    Busek P; Vanickova Z; Hrabal P; Brabec M; Fric P; Zavoral M; Skrha J; Kmochova K; Laclav M; Bunganic B; Augustyns K; Van Der Veken P; Sedo A
    Pancreatology; 2016; 16(5):829-38. PubMed ID: 27320722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.
    Lo A; Wang LS; Scholler J; Monslow J; Avery D; Newick K; O'Brien S; Evans RA; Bajor DJ; Clendenin C; Durham AC; Buza EL; Vonderheide RH; June CH; Albelda SM; Puré E
    Cancer Res; 2015 Jul; 75(14):2800-2810. PubMed ID: 25979873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior.
    Kim GJ; Rhee H; Yoo JE; Ko JE; Lee JS; Kim H; Choi JS; Park YN
    PLoS One; 2014; 9(8):e105094. PubMed ID: 25126747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis.
    Liao Y; Ni Y; He R; Liu W; Du J
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1523-8. PubMed ID: 23835897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
    Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma:
    Watabe T; Liu Y; Kaneda-Nakashima K; Shirakami Y; Lindner T; Ooe K; Toyoshima A; Nagata K; Shimosegawa E; Haberkorn U; Kratochwil C; Shinohara A; Giesel F; Hatazawa J
    J Nucl Med; 2020 Apr; 61(4):563-569. PubMed ID: 31586001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
    Santos AM; Jung J; Aziz N; Kissil JL; Puré E
    J Clin Invest; 2009 Dec; 119(12):3613-25. PubMed ID: 19920354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
    Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
    Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.
    Wang L; Gu F; Ma N; Zhang L; Bian JM; Cao HY
    Tumour Biol; 2013 Aug; 34(4):2309-13. PubMed ID: 23568706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
    Yang X; Lin Y; Shi Y; Li B; Liu W; Yin W; Dang Y; Chu Y; Fan J; He R
    Cancer Res; 2016 Jul; 76(14):4124-35. PubMed ID: 27216177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.